ImmunoGen reports third quarter 2015 financial results
ImmunoGen reported a net loss of $21.6 million, or $0.25 per basic and diluted share, compared to a net loss of $37.5 million, or $0.44 per basic and diluted share, for the same 2014 quarter. Revenues for 3QFY2015 were $11.4 million, compared to $6.9 million for 3QFY2014. April 24, 2015